0 Yorumlar
0 hisse senetleri
21 Views
0 önizleme
Site içinde arama yapın
Yeni insanlarla keşfedin, yeni bağlantılar oluşturmak ve yeni arkadaşlar edinmek
-
Please log in to like, share and comment!
-
Advanced Renal Cell Carcinoma Therapeutics Market: 7.3% CAGR Growth Through 2030According to a newly published market research report by 24LifeSciences, global advanced renal cell carcinoma therapeutics market was valued at USD 3.2 billion in 2023 and is projected to reach USD 5.8 billion by 2030, growing at a compound annual growth rate (CAGR) of 7.3% during the forecast period 20242030. Advanced renal cell carcinoma therapeutics encompass targeted therapies,...0 Yorumlar 0 hisse senetleri 21 Views 0 önizleme
-
Asia-Pacific Natural Killer (NK) Cell Therapeutics Market Size, Share, Trends, Key Drivers, Demand and Opportunity Analysis"In-Depth Study on Executive Summary Asia-Pacific Natural Killer (NK) Cell Therapeutics Market Size and Share The Asia-Pacific natural killer (NK) cell therapeutics market is supportive and aims to reduce the progression of the disease. Data Bridge Market Research analyzes that Asia-Pacific natural killer (NK) cell therapeutics market will grow at a CAGR of 45.2% during the forecast...0 Yorumlar 0 hisse senetleri 276 Views 0 önizleme
-
Asia-Pacific Natural Killer (NK) Cell Therapeutics Market Size, Share, Trends, Key Drivers, Demand and Opportunity Analysis"In-Depth Study on Executive Summary Asia-Pacific Natural Killer (NK) Cell Therapeutics Market Size and Share The Asia-Pacific natural killer (NK) cell therapeutics market is supportive and aims to reduce the progression of the disease. Data Bridge Market Research analyzes that Asia-Pacific natural killer (NK) cell therapeutics market will grow at a CAGR of 45.2% during the forecast...0 Yorumlar 0 hisse senetleri 298 Views 0 önizleme
-
Asia-Pacific Natural Killer (NK) Cell Therapeutics Market Size, Share, Trends, Key Drivers, Growth and Opportunity Analysis"Executive Summary Asia-Pacific Natural Killer (NK) Cell Therapeutics Market: Growth Trends and Share Breakdown The Asia-Pacific natural killer (NK) cell therapeutics market is supportive and aims to reduce the progression of the disease. Data Bridge Market Research analyzes that Asia-Pacific natural killer (NK) cell therapeutics market will grow at a CAGR of 45.2% during the forecast...0 Yorumlar 0 hisse senetleri 1K Views 0 önizleme
-
Basal Cell Carcinoma Therapeutics Market to Reach USD 14.6 Billion by 2032 | CAGR 7.3%According to a newly published market research report by 24LifeSciences, global basal cell carcinoma therapeutics market was valued at USD 8.2 billion in 2024 and is projected to reach USD 14.6 billion by 2032, growing at a compound annual growth rate (CAGR) of 7.3% during the forecast period 2025-2032. Basal Cell Carcinoma (BCC), the most common form of skin cancer accounting for...0 Yorumlar 0 hisse senetleri 2K Views 0 önizleme
-
Bone Metastasis Therapeutics Market Growth & CAGR 8.3% ForecastAccording to a newly published market research report by 24LifeSciences, global bone metastasis therapeutics market was valued at USD 2.5 billion in 2024 and is projected to reach USD 4.9 billion by 2031, growing at a compound annual growth rate (CAGR) of 8.3% during the forecast period 20252031. Bone metastasis therapeutics comprise a critical class of treatments designed to manage secondary...0 Yorumlar 0 hisse senetleri 609 Views 0 önizleme
-
Breakthrough Neuroscience Research Expands AMPA Receptor Therapeutics MarketExecutive Summary α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) Receptor Market Size and Share: Global Industry Snapshot The global α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptor market size was valued at USD 274.69 million in 2024 and is expected to reach USD 431.25 million by 2032, at a CAGR of...0 Yorumlar 0 hisse senetleri 2K Views 0 önizleme
-
Can RNA Therapeutics Unlock a New Era in Disease Treatment?Key Drivers Impacting Executive Summary RNA Therapeutics Market Size and Share CAGR Value During the forecast period of 2025 to 2032 the market is likely to grow at a CAGR of 13.20%, primarily driven by the advancements in mRNA technology, increasing prevalence of chronic diseases, and rising investments in personalized medicine This global RNA Therapeutics Market...0 Yorumlar 0 hisse senetleri 1K Views 0 önizleme
-
Cutting-Edge Ophthalmic Therapies Transforming the Retinal Disease Therapeutics MarketExecutive Summary Retinal Disease Therapeutics Market: Growth Trends and Share Breakdown CAGR Value Data Bridge Market Research analyses that the retinal disease therapeutics market which was USD 12.57 billion in 2022, would reach up to USD 25.69 billion by 2030, and is expected to undergo a CAGR of 9.3% during the forecast period. In this competitive marketplace, businesses are always in...0 Yorumlar 0 hisse senetleri 790 Views 0 önizleme
-
Digital Therapeutics: Redefining Patient EngagementThe healthcare industry is currently undergoing a "software-driven" revolution. For decades, the standard of care revolved almost exclusively around pills, procedures, and physical therapy. Today, a new category of medicine is emerging from our smartphones and wearable devices. Welcome to the era of Digital Therapeutics (DTx). The global Digital Therapeutics Market was valued...0 Yorumlar 0 hisse senetleri 223 Views 0 önizleme
-
Exosome Therapeutics Market Size, Trends, and Growth Forecast 2026-2033The exosome therapeutics industry is witnessing rapid advancement driven by breakthroughs in targeted drug delivery and regenerative medicine. With increasing clinical applications and expanding research investments, the market landscape is evolving dynamically, signaling strong business growth potential and expanding market scope.Market Size and OverviewThe Exosome Therapeutics Market is...0 Yorumlar 0 hisse senetleri 932 Views 0 önizleme
-
Antibody Drug Conjugates Market Expansion with New Cancer TherapiesNorth America currently holds a significant share in the antibody drug conjugates market due to strong research infrastructure and high healthcare spending. The presence of major pharmaceutical companies also supports regional growth. The Antibody Drug Conjugates (ADC) market is projected to grow significantly, reaching US$38,077.45 million by 2031 from US$8,105.65 million in 2023, registering...0 Yorumlar 0 hisse senetleri 3K Views 0 önizleme
-
Are Calcimimetics Shaping the Future of Calcium Disorder Treatments?Calcimimetics Market Summary: According to the latest report published by Data Bridge Market Research, the Calcimimetics Market CAGR Value Calcimimetics Market is the finest market research report whicah is the result of proficient team and their potential capabilities. A strong research methodology consists of data models that include Market Overview and Guide, Vendor...0 Yorumlar 0 hisse senetleri 16 Views 0 önizleme
-
Are Innovative Heart Failure Drugs Changing the Outlook for Cardiovascular Care?Executive Summary Heart Failure Drugs Market Size and Share Forecast CAGR Value Data Bridge Market Research analyses that the heart failure drugs market which was USD 8,010.62 million in 2023, would rocket up to USD 24,919.55 million by 2030, and is expected to undergo a CAGR of 15.56% during the forecast period. This Heart Failure Drugs Market Research Report also conducts analysis...0 Yorumlar 0 hisse senetleri 1K Views 0 önizleme
-
Are Prescription Drugs Driving the Next Era of Global Healthcare Innovation?Key Drivers Impacting Executive Summary Prescription Drugs Market Size and Share CAGR Value The global prescription drugs market size was valued at USD 1,230.28 billion in 2024 and is expected to reach USD 2,451.41 billion by 2032, at a CAGR of 9.00% during the forecast period The large-scale Prescription Drugs Market report presents the best...0 Yorumlar 0 hisse senetleri 1K Views 0 önizleme
-
Biologics and Biosimilars Market by 2031 – Segmentation Analysis, Trends, and Key PlayersThe biologics and biosimilars market is poised for significant growth over the next decade, driven by rising demand for advanced therapies to treat chronic, autoimmune, and life-threatening diseases. Biologics, complex medicines derived from living organisms, are increasingly preferred for their targeted therapeutic effects, while biosimilars offer highly similar alternatives at reduced costs,...0 Yorumlar 0 hisse senetleri 1K Views 0 önizleme
-
Biosimilars Market Opportunities for Pharma and Biotech CompaniesThe increasing role of biosimilars in hospital treatment protocols is another factor driving market growth. Hospitals are adopting biosimilars to manage healthcare budgets effectively. This shift is improving patient access to essential biologic therapies. The global Biosimilars Market is experiencing remarkable growth as healthcare systems increasingly adopt cost-effective alternatives...0 Yorumlar 0 hisse senetleri 2K Views 0 önizleme
Arama Sonuçları
Sponsorluk
Sponsorluk
English
Arabic
French
Spanish
Portuguese
Deutsch
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek